• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组在心力衰竭中的意义。

The Implication of the Gut Microbiome in Heart Failure.

机构信息

Faculty of General Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Faculty of General Medicine, Ovidius University, 900470 Constanta, Romania.

出版信息

Cells. 2023 Apr 14;12(8):1158. doi: 10.3390/cells12081158.

DOI:10.3390/cells12081158
PMID:37190067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10136760/
Abstract

Heart failure is a worldwide health problem with important consequences for the overall wellbeing of affected individuals as well as for the healthcare system. Over recent decades, numerous pieces of evidence have demonstrated that the associated gut microbiota represent an important component of human physiology and metabolic homeostasis, and can affect one's state of health or disease directly, or through their derived metabolites. The recent advances in human microbiome studies shed light on the relationship between the gut microbiota and the cardiovascular system, revealing its contribution to the development of heart failure-associated dysbiosis. HF has been linked to gut dysbiosis, low bacterial diversity, intestinal overgrowth of potentially pathogenic bacteria and a decrease in short chain fatty acids-producing bacteria. An increased intestinal permeability allowing microbial translocation and the passage of bacterial-derived metabolites into the bloodstream is associated with HF progression. A more insightful understanding of the interactions between the human gut microbiome, HF and the associated risk factors is mandatory for optimizing therapeutic strategies based on microbiota modulation and offering individualized treatment. The purpose of this review is to summarize the available data regarding the influence of gut bacterial communities and their derived metabolites on HF, in order to obtain a better understanding of this multi-layered complex relationship.

摘要

心力衰竭是一个全球性的健康问题,对患者的整体健康以及医疗保健系统都有重要影响。近几十年来,大量证据表明,相关的肠道微生物群是人体生理学和代谢稳态的一个重要组成部分,它们可以直接或通过其衍生代谢物影响一个人的健康或疾病状态。人类微生物组研究的最新进展揭示了肠道微生物群与心血管系统之间的关系,揭示了其在心力衰竭相关的生态失调发展中的作用。心力衰竭与肠道生态失调、细菌多样性降低、潜在致病性细菌的肠道过度生长以及产生短链脂肪酸的细菌减少有关。肠道通透性增加允许微生物易位和细菌衍生代谢物进入血液与心力衰竭的进展相关。更深入地了解人类肠道微生物组、心力衰竭和相关危险因素之间的相互作用,对于基于微生物组调节优化治疗策略和提供个体化治疗是必要的。本综述的目的是总结关于肠道细菌群落及其衍生代谢物对心力衰竭影响的现有数据,以更好地理解这种多层次的复杂关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb25/10136760/9ce260e14300/cells-12-01158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb25/10136760/9ce260e14300/cells-12-01158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb25/10136760/9ce260e14300/cells-12-01158-g001.jpg

相似文献

1
The Implication of the Gut Microbiome in Heart Failure.肠道微生物组在心力衰竭中的意义。
Cells. 2023 Apr 14;12(8):1158. doi: 10.3390/cells12081158.
2
The gut microbiome and heart failure: A better gut for a better heart.肠道微生物组与心力衰竭:更好的肠道,更好的心脏。
Rev Endocr Metab Disord. 2019 Dec;20(4):407-414. doi: 10.1007/s11154-019-09519-7.
3
Heart failure developed after myocardial infarction does not affect gut microbiota composition in the rat.心肌梗死后心力衰竭不会影响大鼠的肠道微生物组成。
Am J Physiol Gastrointest Liver Physiol. 2019 Sep 1;317(3):G342-G348. doi: 10.1152/ajpgi.00018.2019. Epub 2019 Jul 17.
4
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.连接免疫系统、系统性慢性炎症和肠道微生物组:性别的作用。
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
5
Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.目前对心力衰竭中肠道微生物组改变及其相关治疗干预策略的认识。
Chin Med J (Engl). 2019 Aug 5;132(15):1843-1855. doi: 10.1097/CM9.0000000000000330.
6
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.肠道菌群失调在心力衰竭的心血代谢危险因素中的新作用。
Curr Hypertens Rep. 2020 May 8;22(5):38. doi: 10.1007/s11906-020-01046-0.
7
Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure.肠道微生物群和短链脂肪酸在心力衰竭中的意义。
Nutrients. 2022 Sep 11;14(18):3758. doi: 10.3390/nu14183758.
8
Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.肠道微生物群与心血管疾病:复杂关系的代谢和炎症背景证据。
Int J Mol Sci. 2023 May 22;24(10):9087. doi: 10.3390/ijms24109087.
9
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的肠道微生物组。
J Am Heart Assoc. 2021 Jul 6;10(13):e020654. doi: 10.1161/JAHA.120.020654. Epub 2021 Jul 2.
10
Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights.揭示肠道微生物群与心力衰竭之间的关系:最新认识与见解。
Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102179. doi: 10.1016/j.cpcardiol.2023.102179. Epub 2023 Nov 3.

引用本文的文献

1
Microbiome and cardiovascular health unexplored frontiers in precision cardiology: a narrative review.微生物群与心血管健康:精准心脏病学中未被探索的前沿领域:一篇综述。
Ann Med Surg (Lond). 2025 May 26;87(7):4255-4261. doi: 10.1097/MS9.0000000000003430. eCollection 2025 Jul.
2
Gut Microbiota and Bacterial Extracellular Vesicles: Emerging Roles in Myocardial Remodelling and Cardiac Health.肠道微生物群与细菌细胞外囊泡:在心肌重塑和心脏健康中的新作用
J Extracell Biol. 2025 Aug 11;4(8):e70079. doi: 10.1002/jex2.70079. eCollection 2025 Aug.
3
The gut-heart axis: a correlation between Paneth cells' dysfunction, microbiome dysbiosis, and cardiovascular diseases.

本文引用的文献

1
Diet-Induced Microbiome's Impact on Heart Failure: A Double-Edged Sword.饮食诱导的微生物组对心力衰竭的影响:一把双刃剑。
Nutrients. 2023 Feb 28;15(5):1223. doi: 10.3390/nu15051223.
2
The Interaction of Gut Microbiota and Heart Failure with Preserved Ejection Fraction: From Mechanism to Potential Therapies.射血分数保留的心力衰竭与肠道微生物群的相互作用:从机制到潜在治疗方法
Biomedicines. 2023 Feb 2;11(2):442. doi: 10.3390/biomedicines11020442.
3
Inflammatory Response: A Crucial Way for Gut Microbes to Regulate Cardiovascular Diseases.
肠-心轴:潘氏细胞功能障碍、微生物群失调与心血管疾病之间的关联
Cell Commun Signal. 2025 Jul 18;23(1):347. doi: 10.1186/s12964-025-02335-4.
4
The link between inflammatory/ SCFA profiles and oral/gut microbiome: an observational study in patients with ST-segment elevation myocardial infarction.炎症/SCFA谱与口腔/肠道微生物群之间的联系:一项针对ST段抬高型心肌梗死患者的观察性研究。
Curr Res Microb Sci. 2025 Jun 15;9:100423. doi: 10.1016/j.crmicr.2025.100423. eCollection 2025.
5
The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure.微生物组关联:连接癌症与心力衰竭的共同途径。
Biomedicines. 2025 May 25;13(6):1297. doi: 10.3390/biomedicines13061297.
6
Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease.肠道-心脏轴中的微生物群:心血管疾病中的代谢产物和机制
Compr Physiol. 2025 Jun;15(3):e70024. doi: 10.1002/cph4.70024.
7
Gut Microbiota in Heart Failure-The Role of Inflammation.心力衰竭中的肠道微生物群——炎症的作用。
Biomedicines. 2025 Apr 9;13(4):911. doi: 10.3390/biomedicines13040911.
8
Oxidative Stress, Gut Microbiota, and Extracellular Vesicles: Interconnected Pathways and Therapeutic Potentials.氧化应激、肠道微生物群与细胞外囊泡:相互关联的途径及治疗潜力
Int J Mol Sci. 2025 Mar 28;26(7):3148. doi: 10.3390/ijms26073148.
9
Deciphering the causality of gut microbiota, circulating metabolites and heart failure: a mediation mendelian.解读肠道微生物群、循环代谢物与心力衰竭之间的因果关系:一种中介孟德尔分析方法
Front Pharmacol. 2025 Apr 1;16:1531384. doi: 10.3389/fphar.2025.1531384. eCollection 2025.
10
Diet and the gut microbiota profiles in individuals at risk of chronic heart failure - A review on the Asian population.慢性心力衰竭高危个体的饮食与肠道微生物群特征——关于亚洲人群的综述
Asia Pac J Clin Nutr. 2025 Apr;34(2):141-152. doi: 10.6133/apjcn.202504_34(2).0001.
炎症反应:肠道微生物调节心血管疾病的关键途径。
Nutrients. 2023 Jan 24;15(3):607. doi: 10.3390/nu15030607.
4
Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure.严重慢性心力衰竭患者肠道微生物群和代谢物苯乙酰谷氨酰胺的改变
Front Cardiovasc Med. 2023 Jan 10;9:1076806. doi: 10.3389/fcvm.2022.1076806. eCollection 2022.
5
The Role of Intestinal Flora and Its Metabolites in Heart Failure.肠道菌群及其代谢产物在心力衰竭中的作用
Infect Drug Resist. 2023 Jan 5;16:51-64. doi: 10.2147/IDR.S390582. eCollection 2023.
6
The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders.肠道微生物群及其在黏膜性消化系统疾病中的意义。
Biomedicines. 2022 Dec 2;10(12):3117. doi: 10.3390/biomedicines10123117.
7
Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure.肠道微生物群衍生的苯乙酰谷氨酰胺与心力衰竭。
Circ Heart Fail. 2023 Jan;16(1):e009972. doi: 10.1161/CIRCHEARTFAILURE.122.009972. Epub 2022 Dec 16.
8
Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds.氧化三甲胺(TMAO)和甜菜碱对人类健康的影响:超越渗透保护化合物的范畴
Front Mol Biosci. 2022 Aug 26;9:964624. doi: 10.3389/fmolb.2022.964624. eCollection 2022.
9
The role of gut dysbiosis-associated inflammation in heart failure.肠道微生物群失调相关炎症在心力衰竭中的作用。
Rev Assoc Med Bras (1992). 2022 Aug;68(8):1120-1124. doi: 10.1590/1806-9282.20220197.
10
Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis.肠道微生物衍生色氨酸代谢物维持肠道和全身稳态。
Cells. 2022 Jul 25;11(15):2296. doi: 10.3390/cells11152296.